Free Physician Masterclass: The Evidence-Based Guide to Semaglutide, Tirzepatide & the Drug That Just Shattered Every Weight Loss Record in Clinical Trial History
Here’s what actually happens in most GLP-1 prescriptions: you get a starting dose, a follow-up appointment in 90 days, and almost no clinical guidance for the protocol that actually determines your outcome. No baseline labs. No muscle preservation protocol. No titration strategy. No plan for what happens when you stop. The medication alone does not produce the results the clinical trials show — the protocol does. This free masterclass is the clinical education your prescriber doesn’t have time to give you.
Why 25–39% of weight lost on GLP-1 can be muscle — and the exact four-pillar protocol that prevents it (STEP trial DXA data)
The complete Phase 3 trial evidence — SUSTAIN-6, LEADER, SELECT (17,604 patients with no diabetes), SURMOUNT-5, and TRIUMPH-4 retatrutide data — explained in plain clinical language
Semaglutide vs. tirzepatide vs. retatrutide — how to choose based on your metabolic profile, HbA1c, HOMA-IR, and cardiovascular risk
The titration protocol that eliminates 80% of side effects — the three clinical rules most prescribers never share with their patients
What the STEP 4 and SURMOUNT-4 withdrawal data means for you — and how to build the metabolic infrastructure that prevents weight regain after stopping
Reserve Your Free Spot
Sessions fill quickly. The next available time is shown above.
Replay available for registered attendees for 48 hours.
75 minutes of complete physician-grade clinical education in GLP-1 pharmacology, trial evidence, and optimization protocol — not a sales pitch disguised as content.
Verified reviews and attendee feedback from the GLP-1 Masterclass
"I’ve been on Ozempic for 3 months and nobody told me any of this. The muscle loss data alone was worth the hour. I started creatine the next day and finally feel like I’m doing this right. The bedtime injection tip immediately changed my mornings."
"My doctor mentioned GLP-1 last week and I had no idea what I was getting into. This masterclass gave me more useful clinical information in 75 minutes than I could have found in weeks of research on my own. I went into my next appointment with the right questions."
"The brain effect finally makes sense to me — I noticed the food noise quieting in week 2 and didn’t understand why. Dr. Baird’s explanation of the neurological mechanism changed how I think about this medication entirely. I’ve already shared this with my NP."
In 35 years of practicing medicine and treating over 20,000 patients, I have watched GLP-1 medications go from niche diabetes agents to the most significant metabolic intervention in modern medicine. And in that same period, I have watched most patients receive almost no clinical support for using them correctly.
The clinical trial results people see in headlines — the 15%, 20%, 22% weight loss figures — are what happens with the full protocol. What most patients actually experience is the medication without the muscle preservation strategy, without the correct titration, without the baseline labs, and without a plan for what happens after. The gap between those two outcomes is what this masterclass exists to close.
In this free training, I share the complete clinical framework I use with my own patients at Rejuv Medical Louisville — including the trial data, the drug selection logic, and the exact optimization protocol — so you can finally use these medications the way the evidence says they should be used.
You are a physician, NP, or clinician building a structured GLP-1 prescribing and optimization framework
You are currently on semaglutide or tirzepatide and want to know if you are using it correctly
You are considering GLP-1 therapy and want the actual Phase 3 data before you decide
You have obesity, type 2 diabetes, prediabetes, or metabolic syndrome and want physician-grade guidance
You are worried about muscle loss, side effects, or weight regain after stopping — and want clinical answers
You want to understand retatrutide and the 2026–27 GLP-1 pipeline before it reaches mainstream prescribing
You want a quick fix and are not open to building the metabolic infrastructure the medication requires
You are not open to adjusting your protocol based on what the clinical trial data actually shows
You expect the medication to do all the work without addressing nutrition, resistance training, or lab monitoring
You are looking for this to replace your relationship with your treating physician
Verified patient reviews of Dr. John R. Baird, MD · John Baird, MD, PLLC · Louisville, KY